PMID: 577329Jun 1, 1977

C-peptide in diabetic children after stimulation with clucagon compared with fasting C-peptide levels in non-diabetic children

Acta Endocrinologica
J Ludvigsson, L G Heding

Abstract

Fasting serum C-peptide and total immunoreactive insulin (IRI) were determined in 38 non-diabetic children and adolescents 6-22 years old. C-peptide varied between 0.22-0.73 pmol/ml (mean +/- SD, 0.45 +/- 0.11). There was a tendency to higher values during puberty. No difference was found between subjects with or without a family history for diabetes. IRI varied between 0-31 millimcron/m1 (mean +/- SD, 11.3 +/- 6.5). The C-peptide response to glucagon was studied in 10 insulin dependent juvenile diabetics 11-19 years old, who had had measurable amounts of fasting C-peptide on some occasions during the previous years. Duration of diabetes varied between 4-12 years. A slight but significant rise in C-peptide level occurred in 3 patients. Their metabolic control estimated on the basis of daily urinalysis was "excellent" or "good". The results support the hypothesis that even trace remnants of the beta cell function may be of importance for the metabolic control in juvenile diabetes.

References

Jul 24, 2001·Archives of Disease in Childhood·J LudvigssonG Berlin
Jan 1, 1984·Critical Reviews in Clinical Laboratory Sciences·A M Bonser, P Garcia-Webb
Sep 1, 1995·Diabetic Medicine : a Journal of the British Diabetic Association·I N MigdalisM Samartzis
Jan 1, 1983·Acta Medica Scandinavica. Supplementum·J Ludvigsson

Related Concepts

Urinalysis
Glucagon (rDNA)
Intravenous Injections
C-Peptide
Glucagon
Insulin C-peptide Measurement
Urinalysis; Qualitative or Semiquantitative, Except Immunoassays
Glucagon Measurement
Novolin
Fasting

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.